| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |